DXB 3.33% 43.5¢ dimerix limited

Ann: DMX-200 Competitive Position Further Enhanced, page-64

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274
    Hi HS, both companies do have GMP manufactured drug stock approved by FDA. I get it with in vitro (this data), but you can’t just take a novel patented drug, test it & put out data on 2 publicly listed companies (one on the NASDAQ) without the other being aware or vice/versa. Glad DXB put in that patent application for potentially the new gold standard over ARB. You can’t just cook up a compound & go with it. Dimerix might be ridiculed for many things, but rushing the gun & lack of professionalism & process in clinical trials, no way.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
43.5¢
Change
-0.015(3.33%)
Mkt cap ! $239.5M
Open High Low Value Volume
43.5¢ 43.8¢ 42.0¢ $988.7K 2.301M

Buyers (Bids)

No. Vol. Price($)
1 10000 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.5¢ 17061 1
View Market Depth
Last trade - 16.10pm 04/09/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.